scholarly article | Q13442814 |
P50 | author | Michele Bonus | Q58661904 |
Erwin Lamping | Q64008617 | ||
Richard Cannon | Q42745521 | ||
P2093 | author name string | Lutz Schmitt | |
Holger Gohlke | |||
Kyoko Niimi | |||
Masakazu Niimi | |||
Koichi Tanabe | |||
Ariya Chindamporn | |||
Minoru Nagi | |||
Kunji Miyoshi | |||
Susumu Tomiyama | |||
P2860 | cites work | I-TASSER server for protein 3D structure prediction | Q21284202 |
Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding | Q24657908 | ||
Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP | Q27643828 | ||
Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain | Q27679289 | ||
Refined structures of mouse P-glycoprotein | Q27680445 | ||
Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae | Q27934012 | ||
ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p | Q27936618 | ||
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information | Q29615720 | ||
Epidemiology of invasive candidiasis: a persistent public health problem | Q29616758 | ||
Structure of a bacterial multidrug ABC transporter | Q29617308 | ||
Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein | Q30252970 | ||
Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. | Q32133639 | ||
Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative | Q33200348 | ||
Fungal PDR transporters: Phylogeny, topology, motifs and function. | Q33624643 | ||
ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans | Q33755825 | ||
The ABC of ABCS: a phylogenetic and functional classification of ABC systems in living organisms | Q33952573 | ||
Prospective study of Candida species in patients at a comprehensive cancer center | Q33982572 | ||
Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters | Q33983544 | ||
The signaling interface of the yeast multidrug transporter Pdr5 adopts a cis conformation, and there are functional overlap and equivalence of the deviant and canonical Q-loop residues | Q34196332 | ||
Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor | Q34334444 | ||
Assessing the local structural quality of transmembrane protein models using statistical potentials (QMEANBrane). | Q42848308 | ||
Functional impact of a single mutation within the transmembrane domain of the multidrug ABC transporter Pdr5. | Q43574790 | ||
Beauvericin counteracted multi-drug resistant Candida albicans by blocking ABC transporters. | Q44606676 | ||
Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520. | Q44931220 | ||
Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux. | Q46529075 | ||
Inhibition of fungal ABC transporters by unnarmicin A and unnarmicin C, novel cyclic peptides from marine bacterium | Q46925925 | ||
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. | Q51180154 | ||
Mutational analysis of the yeast multidrug resistance ABC transporter Pdr5p with altered drug specificity. | Q53750874 | ||
The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility. | Q54059367 | ||
Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function | Q84898935 | ||
A conserved interdomain communication pathway of pseudosymmetrically distributed residues affects substrate specificity of the fungal multidrug transporter Cdr1p | Q34466101 | ||
Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. | Q34561878 | ||
The evolution of drug resistance in clinical isolates of Candida albicans | Q35248451 | ||
Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p. | Q35656711 | ||
Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae | Q35947069 | ||
Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates | Q36095337 | ||
Dual action antifungal small molecule modulates multidrug efflux and TOR signaling | Q36116026 | ||
An update on antifungal targets and mechanisms of resistance in Candida albicans | Q36235037 | ||
A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5. | Q36516207 | ||
Milbemycins: more than efflux inhibitors for fungal pathogens | Q36558410 | ||
The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters | Q36669332 | ||
Mutations define cross-talk between the N-terminal nucleotide-binding domain and transmembrane helix-2 of the yeast multidrug transporter Pdr5: possible conservation of a signaling interface for coupling ATP hydrolysis to drug transport | Q37000251 | ||
Crystal structure of the human sterol transporter ABCG5/ABCG8. | Q37135756 | ||
Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance | Q37144914 | ||
Efflux-mediated antifungal drug resistance. | Q37156645 | ||
The deviant ATP-binding site of the multidrug efflux pump Pdr5 plays an active role in the transport cycle | Q37234052 | ||
Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29. | Q37428726 | ||
Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity | Q37591245 | ||
ABC transporters: a riddle wrapped in a mystery inside an enigma | Q37596128 | ||
Multidrug efflux pumps: substrate selection in ATP-binding cassette multidrug efflux pumps--first come, first served? | Q37644557 | ||
The multidrug transporter Pdr5: a molecular diode? | Q37824859 | ||
Yeast ATP-binding cassette transporters conferring multidrug resistance | Q38019037 | ||
Candida glabrata ATP-binding cassette transporters Cdr1p and Pdh1p expressed in a Saccharomyces cerevisiae strain deficient in membrane transporters show phosphorylation-dependent pumping properties | Q38362728 | ||
An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones | Q41183764 | ||
Structure of the human multidrug transporter ABCG2. | Q41597764 | ||
Chemosensitization as a means to augment commercial antifungal agents | Q42141903 | ||
Insight into pleiotropic drug resistance ATP-binding cassette pump drug transport through mutagenesis of Cdr1p transmembrane domains. | Q42563449 | ||
Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension. | Q42676608 | ||
Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric | Q42745431 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Candida albicans | Q310443 |
transmembrane protein | Q424204 | ||
Saccharomyces cerevisiae | Q719725 | ||
P577 | publication date | 2018-12-21 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops. | |
P478 | volume | 63 |
Search more.